Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent-Reference-Cited by-同舟云学术

Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent

Published:2021-01 Issue:1 Volume:35 Page:265-266
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Levy Jerrold H.,Connors Jean M.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Reversal agents for non-vitamin K antagonist oral anticoagulants;Levy;Nat Rev Cardiol,2018

2. When and how to use antidotes for the reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH;Levy;J Thromb Haemost,2016

3. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors;Connolly;N Engl J Med,2019

4. Dabigatran reversal with idarucizumab in patients requiring urgent surgery: A subanalysis of the RE-VERSE AD study [e-pub ahead of print];Levy;Ann Surg,2019

5. Intraoperative off-label reversal of apixaban by andexanet alfa while on VA-ECMO immediately after emergent surgery for acute type A aortic dissection [e-pub ahead of print];Kainz;J Cardiothorac Vasc Anesth,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Perioperative Protamine Reactions in Patients With Fish Allergies: A Retrospective Observational Study;Journal of Cardiothoracic and Vascular Anesthesia;2024-08

2. A Case of Andexanet Alfa Induced Heparin Resistance in Emergent Aortic Surgery: Successful Anticoagulation Management Using Antithrombin Administration;Cureus;2023-12-20

3. Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects;British Journal of Anaesthesia;2023-12

4. End-on PEGylation of heparin: Effect on anticoagulant activity and complexation with protamine;International Journal of Biological Macromolecules;2023-09

5. Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance;Cureus;2023-08-23